Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05691725

Evaluation of Peripheral Neutrophils in Antisynthetase Syndrome

Conditions: Antisynthetase Syndrome

Sex: All
Ages: 18 Years – N/A
Enrollment: 40
Sponsor: Central Hospital, Nancy, France

Location: France

Summary

Antisynthetase syndrome (AS) is a rare overlapping myositis characterized by cellular and humoral autoimmune responses directed against aminoacyl-tRNA synthetases. A pathogenic role of neutrophils was described during inflammatory myopathies, with increased netosis correlated with disease activity and muscle damage. Higher number of alveolar neutrophils was observed in patients with rapidly progressive forms of interstitial lung disease.Peripheral neutrophils could represent a simple biomarker of severity and activity in patients with antisynthetase syndrome.The main objective is to compare circulating neutrophils between severe and non severe patients with antisynthetase syndrome. Secondary objectives are: 1) to evaluate correlation between circulating neutrophils and organ-specific severity, 2) to compare circulating neutrophils at time of diagnosis and circulating neutrophils after 6 months of treatment in patients with antisynthetase syndrome.

Eligibility Criteria

Inclusion Criteria:Patients with antisyntheatse syndrome according to Solomon criteria

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05691725). StuddyBuddy aggregates publicly available trial information.